Search
-
Personify Health & Ipsos Release New Report on U.S. Employee Health and Productivity Trends
New survey sheds light on importance of investing in employee health, benefits navigation, and beyond-basic health needs
-
Ways digital payment options will keep Americans spending
From cashless kiosks to real-time payments, money is changing hands in new ways. Payments Dive’s Lynne Marek explains just how commerce is changing.
-
Does AI have a halo with B2B buyers?
Here’s what marketers need to know about B2B buyers and users when positioning AI-powered software.
-
Nearly three in five registered voters in Florida favor expanding abortion access via ballot measure
The latest USA Today/Ipsos poll finds that white Floridians are more likely than Hispanic Floridians to say they will vote for state abortion legalization
-
INTELLUS SUMMIT: Modeling the Impact of Patient and HCP Influence on Rx Behavior
Be sure to join us for our presentation, Modeling the Impact of Patient and HCP Influence on Prescribing Behavior and Informing Audience-specific Marketing Spend
-
What the Future: Wellness
Watch our foresight webinar as we explore the future of wellness and how businesses across industries can support consumers with their goals.
-
How political, economic and climate uncertainty will shape the future of risk
If you can’t be certain, you can be prepared. What the Future Editor Matt Carmichael looks at how brands and businesses can err on the side of caution in risky times.
-
How understanding consumers’ risk tolerance can drive engagement
People try to take calculated risks — but that doesn’t mean they do their math the same way. Ipsos’ Nathan Rosenstein looks explains why brands should understand the behavioral science behind uncertainty.
-
Xpectives.Health Summit
This premier event will unlock the latest trends, strategies, and insights to help you effectively market your prescription products to healthcare professionals.
-
Most Americans support access to medication abortion
Axios/Ipsos poll: Four in five Americans say the FDA should continue approving and regulating medicines in the U.S.